Becton Dickinson & Co. (NYSE:BDX) said Tuesday it closed its purchase of biotech firm Cellular Research for an undisclosed price. Cellular Research develops tools for parallel single cell genetic analysis based upon its proprietary molecular indexing technology, according to Franklin Lakes, N.J.-based Becton Dickinson. “The acquisition of Cellular Research, combined with our existing cell sorting technology, […]